Alto Neuroscience, Valuation
| ANRO Stock | 4.28 0.05 1.15% |
At this time, the firm appears to be undervalued. Alto Neuroscience, shows a prevailing Real Value of USD11.07 per share. The current price of the firm is USD4.28. Our model approximates the value of Alto Neuroscience, from analyzing the firm fundamentals such as Current Valuation of 184.12 M, shares owned by insiders of 13.11 %, and Number Of Shares Shorted of 3.06 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Alto Neuroscience,'s valuation include:
Price Book 2.0424 | Enterprise Value 184.1 M |
Undervalued
Today
Please note that Alto Neuroscience,'s price fluctuation is relatively risky at this time. Calculation of the real value of Alto Neuroscience, is based on 3 months time horizon. Increasing Alto Neuroscience,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Alto Neuroscience, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Alto Stock. However, Alto Neuroscience,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.28 | Real 11.07 | Target 31.5 | Hype 4.05 |
The intrinsic value of Alto Neuroscience,'s stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Alto Neuroscience,'s stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Alto Neuroscience, helps investors to forecast how Alto stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Alto Neuroscience, more accurately as focusing exclusively on Alto Neuroscience,'s fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Alto Neuroscience,'s intrinsic value based on its ongoing forecasts of Alto Neuroscience,'s financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Alto Neuroscience,'s closest peers.
Alto Neuroscience, Cash |
|
Alto Valuation Trend
Knowing Alto Neuroscience,'s actual value is paramount for traders when making sound investment determinations. Using both Alto Neuroscience,'s enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
Alto Neuroscience, Total Value Analysis
Alto Neuroscience, is presently projected to have valuation of 184.12 M with market capitalization of 367.18 M, debt of 151.46 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Alto Neuroscience, fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
184.12 M | 367.18 M | 151.46 M |
Alto Neuroscience, Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The recent return on assets of Alto suggests not a very effective usage of assets in November.Alto Neuroscience, Ownership Allocation
Alto Neuroscience, holds a total of 26.96 Million outstanding shares. The majority of Alto Neuroscience, outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Alto Neuroscience, to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Alto Neuroscience,. Please pay attention to any change in the institutional holdings of Alto Neuroscience, as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Alto Neuroscience, Profitability Analysis
Net Loss for the year was (36.3 M) with profit before overhead, payroll, taxes, and interest of 0.About Alto Neuroscience, Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Alto Neuroscience,. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Alto Neuroscience, based exclusively on its fundamental and basic technical indicators. By analyzing Alto Neuroscience,'s financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Alto Neuroscience,'s intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Alto Neuroscience,. We calculate exposure to Alto Neuroscience,'s market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Alto Neuroscience,'s related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | -335.7 K | -352.5 K | |
| Pretax Profit Margin | (39.37) | (41.34) | |
| Operating Profit Margin | (51.67) | (54.25) | |
| Net Loss | (39.37) | (41.34) | |
| Gross Profit Margin | 0.28 | 0.25 |
Alto Neuroscience, Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 26.9 M |
Alto Neuroscience, Current Valuation Indicators
Alto Neuroscience,'s valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Alto Neuroscience,'s valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Alto Neuroscience,, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Alto Neuroscience,'s valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Alto Neuroscience,'s worth.When determining whether Alto Neuroscience, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Alto Neuroscience,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Alto Neuroscience, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Alto Neuroscience, Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alto Neuroscience,. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Alto Stock, please use our How to Invest in Alto Neuroscience, guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alto Neuroscience,. If investors know Alto will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alto Neuroscience, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.85) |
The market value of Alto Neuroscience, is measured differently than its book value, which is the value of Alto that is recorded on the company's balance sheet. Investors also form their own opinion of Alto Neuroscience,'s value that differs from its market value or its book value, called intrinsic value, which is Alto Neuroscience,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alto Neuroscience,'s market value can be influenced by many factors that don't directly affect Alto Neuroscience,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alto Neuroscience,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Alto Neuroscience, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alto Neuroscience,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.